Naegleria fowleri: Difference between revisions
From IDWiki
Naegleria fowleri
(Created page with "* Protozoan parasite that causes '''primary amebic meningoencephalitis (PAM)''' * Found in warm fresh-water, including southern US * Infection (PAM) is rapidly-progressing and...") Â |
(→â€)  |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
+ | ==Background== |
||
⚫ | |||
+ | ===Microbiology=== |
||
+ | * One of the [[free-living amoebae]] |
||
+ | |||
+ | ===Epidemiology=== |
||
* Found in warm fresh-water, including southern US |
* Found in warm fresh-water, including southern US |
||
⚫ | |||
+ | ==Clinical Manifestations== |
||
⚫ | |||
⚫ | |||
+ | |||
+ | ==Management== |
||
+ | * Unclear optimal management |
||
+ | * CDC recommendations are: |
||
+ | ** [[Is treated by::Amphotericin B]] 0.75 mg/kg IV q12h for three days followed by 1 mg/kg IV daily for 11 days, concurrent with |
||
+ | ** [[Is treated by::Amphotericin B]] 1.5 mg intrathecal once daily for 2 days followed by 1 mg intrathecal q2d for 8 days, concurrent with |
||
+ | ** [[Is treated by::Azithromycin]] 10 mg/kg (max 500 mg) PO/IV daily, plus [[Is treated by::fluconazole]] 10 mg/kg (max 600 mg) PO/IV daily, plus [[Is treated by::rifampin]] 10 mg/kg (max 600 mg) PO/IV daily, plus [[Is treated by::miltefosine]] 50 mg PO bid or tid for 28 days, concurrent with |
||
+ | ** [[Is treated by::Dexamethasone]] 0.15 mg/kg IV q6h during the initial 4 days |
||
{{DISPLAYTITLE:''Naegleria fowleri''}} |
{{DISPLAYTITLE:''Naegleria fowleri''}} |
||
+ | * Note that the recommendation is specifically for conventional rather than liposomal [[amphotericin B]] |
||
+ | * [[Miltefosine]] dosing is bid if weight <45 kg and tid if weight ≥45 kg |
||
+ | |||
[[Category:Protozoa]] |
[[Category:Protozoa]] |
Latest revision as of 16:29, 18 February 2022
Background
Microbiology
- One of the free-living amoebae
Epidemiology
- Found in warm fresh-water, including southern US
Clinical Manifestations
- Causes acute, aggressive primary amebic meningoencephalitis (PAM)
- Infection (PAM) is rapidly-progressing and almost uniformly fatal (141/145 cases in the US)
Management
- Unclear optimal management
- CDC recommendations are:
- Amphotericin B 0.75 mg/kg IV q12h for three days followed by 1 mg/kg IV daily for 11 days, concurrent with
- Amphotericin B 1.5 mg intrathecal once daily for 2 days followed by 1 mg intrathecal q2d for 8 days, concurrent with
- Azithromycin 10 mg/kg (max 500 mg) PO/IV daily, plus fluconazole 10 mg/kg (max 600 mg) PO/IV daily, plus rifampin 10 mg/kg (max 600 mg) PO/IV daily, plus miltefosine 50 mg PO bid or tid for 28 days, concurrent with
- Dexamethasone 0.15 mg/kg IV q6h during the initial 4 days
- Note that the recommendation is specifically for conventional rather than liposomal amphotericin B
- Miltefosine dosing is bid if weight <45 kg and tid if weight ≥45 kg